MIT Course Numbers: MAS.961 ~ 9.917 ~ HST.588
Instructors: J. Bonsen ~ E.S. Boyden ~ R.G. Ellis-Behnke
Units: H-level ~ 2-0-4 Units
Time: Tuesdays, 7-9pm (8-10pm after daylight savings begins); Begins Tues Feb 6, 2007
Place: Room 46-3002
Special note: Class sessions will be live link to University of Hong Kong
Neurotechnology Ventures is a new seminar and project-oriented course on the challenges of envisioning, planning, and building startups to bring neuroengineering innovations to the world.
Each 2-hour class begins with a survey of a broad topic area, and continues with a live-case study of a current, specific, development or commercialization effort in that area. Explorations will cover a broad array of issues ranging from the deeply technical, to the analysis of market realities.
Topics Include: Neuroimaging, Neurology/Psychiatry Diagnosis, Rehabilitation, Neurosurgery, Neuropharmacology, Brain Stimulation, Prosthetics, Sensory and Motor Augmentation, Regenerative Neuromedicine, and more.
Limited Enrollment: Open to advanced students by permission of instructors. Email firstname.lastname@example.org two paragraphs summarizing your: (1) Professional Skills & Experience, and (2) Inventive/Entrepreneurial Aspirations.
Student Project: Students will work in teams to analyze an opportunity and create a business plan executive summary to solve a major problem through neurotechnology. The project will develop throughout the term, culminating in a final presentation. We expect that some projects may go on to become successful ventures.
ScheduleTues., Feb. 6 Overview of class, goals, networking
Tues., Feb. 13 Shai Gozani, Founder & CEO of NeuroMetrix, Noninvasive Neurological Diagnostic and Therapeutic Solutions
Tues., Feb. 20 first teambuilding event
Tues., Feb. 27 Steve Kelly, CEO of Myomo, NeuroRobotics for stroke therapy
Tues., Mar. 6 Rutledge Ellis-Behnke, Jerry Schneider, Peptides, Clotting, and Spinal Cord Injury
Tues., Mar. 13 First round of presentations
Tues., Mar. 20 Richard Wurtman, MIT professor, Neuropharmaceuticals and Clinical Trials in Academia
Tues., Mar. 27 Beran Rose, Boston Scientific, Corporate R&D in Neurotechnology
Tues., Apr. 3rd Daniel Lee, Biogen IDEC, Multiple Sclerosis Therapy
Tues., Apr. 24th Carl Marci, MGH Psychiatry, Emotion, Psychiatry, and Neuromarketing
Thurs., May 3 Michael Merzenich, UCSF professor, co-founder of Scientific Learning and Posit Science, in room E15-209 (note changed date!).
Tues., May 15 Final student presentations
(C) 2007-present, Bonsen, Boyden, Ellis-Behnke